Download the app
App StorePlay Store
Beige
Login
← All tags

diagnostics

Thyrocare Q4 profit soars 128% to Rs 48.7 crore on scale and new diagnostics

Thyrocare Q4 profit soars 128% to Rs 48.7 crore on scale and new diagnostics

PharmEasy-owned Thyrocare Technologies reported a 128% year-on-year jump in Q4 FY26 consolidated net profit to Rs 48.7 crore, driven by operating leverage and volume growth. Revenue from operations rose 20% to Rs 224 crore. Tests processed surged 29% to 5.9 crore, while margins improved. The company also launched advanced allergy testing and entered genomics with NIPT.

Summarised by Beize from a story on Inc42 on 7 May 2026
Swaasa AI can detect lung diseases from coughs using only a smartphone

Swaasa AI can detect lung diseases from coughs using only a smartphone

Swaasa AI is developing a smartphone-based cough sound analysis platform to screen respiratory conditions like COPD, asthma, and pneumonia. By using audio signals instead of traditional spirometry, the tool could make lung disease detection faster, cheaper, and more accessible—particularly in regions where spirometry testing is hard to get.

Summarised by Beize from a story on The Economic Times on 7 May 2026

Your news, in seconds

App StorePlay Store
Harvard study finds AI diagnoses beat two human doctors in emergency room tests

Harvard study finds AI diagnoses beat two human doctors in emergency room tests

A Harvard-backed study tests large language models across multiple medical scenarios, including real emergency room cases. The researchers report that at least one AI model performed more accurately than two human doctors, raising questions about how these systems could support urgent care workflows and where their limits may still be.

Summarised by Beize from a story on TechCrunch on 4 May 2026
LordsMark gets HIV self test approval one of just nine global players set to export worldwide

LordsMark gets HIV self test approval one of just nine global players set to export worldwide

Lord’s Mark Industries has won Central Licensing Authority clearance for its LordsMed HIV 1&2 Self Test, joining a limited group of just nine global companies with Class D in-vitro diagnostic self-test approval. Exports are slated to start in June 2026 to Africa, the EU and South America, with the firm targeting major international markets.

Summarised by Beize from a story on The Economic Times on 1 May 2026
Doctors may predict death within 24 hours using a simple bedside eye reflex test study finds

Doctors may predict death within 24 hours using a simple bedside eye reflex test study finds

A new BMJ Supportive and Palliative Care study suggests clinicians could estimate whether a patient may die within 24 hours using a quick bedside check. Researchers report that lack of the corneal reflex, the eye’s automatic blink response, is strongly linked to imminent death, with those showing no reflex far more likely to deteriorate within a day.

Summarised by Beize from a story on The Economic Times on 26 Apr 2026
CENT launches Bengaluru prevention centre to standardise AI early disease detection across India

CENT launches Bengaluru prevention centre to standardise AI early disease detection across India

As India’s healthcare race heats up, preventive tech startup CENT has opened a 7,000 sq ft clinical screening centre in Bengaluru. Built to standardise AI-driven early detection, it aims to find life-threatening conditions in people without symptoms using a CCNM Protocol covering cardiac, cancer, neurological and metabolic tests, including whole-body MRI and ultra-low-dose cardiac CT.

Summarised by Beize from a story on YourStory on 24 Apr 2026

Never miss a story

App StorePlay Store
Page 1

The full experience is on mobile.

Swipe through stories, personalise your feed, and save articles for later — all on the app.

Download on the App StoreGet it on Google Play